(Q38369228)

2 September 2017

1 reference

title

Compounds for imaging amyloid-β deposits in an Alzheimer's brain: a patent review (English)

1 reference

2 September 2017

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25746836%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

author name string

Peiyu Tu

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25746836%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Hualong Fu

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25746836%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

language of work or name

English

0 references

publication date

8 March 2015

1 reference

Expert Opinion on Therapeutic Patents

2 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25746836%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25746836%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25746836%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

page(s)

413-423

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25746836%20AND%20SRC:MED&resulttype=core&format=json

2014 Alzheimer's disease facts and figures

5 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1007953

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1007953

The β-Amyloid Hypothesis in Alzheimer's Disease: Seeing Is Believing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1007953

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1007953

Advances in PET imaging of P-glycoprotein function at the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1007953

Past and recent progress of molecular imaging probes for β-amyloid plaques in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1007953

19F and 1H MRI detection of amyloid beta plaques in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1007953

Design and chemical synthesis of a magnetic resonance contrast agent with enhanced in vitro binding, high blood-brain barrier permeability, and in vivo targeting to Alzheimer's disease amyloid plaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1007953

Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance microimaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1007953

PET/SPECT imaging agents for neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1007953

Fluorescence molecular tomography: principles and potential for pharmaceutical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1007953

Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1007953

Neurovascular mechanisms of Alzheimer's neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1007953

Conformation-dependent antibodies target diseases of protein misfolding

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1007953

Binding of Congo red to amyloid protofibrils of the Alzheimer Aβ(9-40) peptide probed by molecular dynamics simulations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1007953

Chrysamine-G binding to Alzheimer and control brain: autopsy study of a new amyloid probe

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1007953

Imaging Abeta plaques in living transgenic mice with multiphoton microscopy and methoxy-X04, a systemically administered Congo red derivative

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1007953

Protein-induced photophysical changes to the amyloid indicator dye thioflavin T

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1007953

Development of positron emission tomography β-amyloid plaque imaging agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1007953

Detection of amyloid in Alzheimer's disease with positron emission tomography using [11C]AZD2184.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1007953

AZD2184: a radioligand for sensitive detection of beta-amyloid deposits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1007953

Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1007953

Bioavailability of curcumin: problems and promises

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1007953

Design, synthesis, and testing of difluoroboron-derivatized curcumins as near-infrared probes for in vivo detection of amyloid-beta deposits

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1007953

A bifunctional curcumin analogue for two-photon imaging and inhibiting crosslinking of amyloid beta in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1007953

Design and synthesis of curcumin analogues for in vivo fluorescence imaging and inhibiting copper-induced cross-linking of amyloid beta species in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1007953

PET of brain amyloid and tau in mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1007953

Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy: the 3-year, multicenter, comparative Aldose Reductase Inhibitor-Diabetes Complications Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1007953

Rhodanine-based tau aggregation inhibitors in cell models of tauopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1007953

Rhodanine and thiohydantoin derivatives for detecting tau pathology in Alzheimer's brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1007953

Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1007953

Common mechanisms of amyloid oligomer pathogenesis in degenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1007953

Alzheimer's amyloid story finds its star.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1007953

Soluble protein oligomers as emerging toxins in Alzheimer's and other amyloid diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1007953

A chemical screening approach reveals that indole fluorescence is quenched by pre-fibrillar but not fibrillar amyloid-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1007953